These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 15265949)

  • 1. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB
    J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
    Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD
    J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85.
    Boggiano C; Moya R; Pinilla C; Bihl F; Brander C; Sidney J; Sette A; Blondelle SE
    Eur J Immunol; 2005 May; 35(5):1428-37. PubMed ID: 15789356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.
    Goulder PJ; Altfeld MA; Rosenberg ES; Nguyen T; Tang Y; Eldridge RL; Addo MM; He S; Mukherjee JS; Phillips MN; Bunce M; Kalams SA; Sekaly RP; Walker BD; Brander C
    J Exp Med; 2001 Jan; 193(2):181-94. PubMed ID: 11148222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.
    Goulder PJ; Sewell AK; Lalloo DG; Price DA; Whelan JA; Evans J; Taylor GP; Luzzi G; Giangrande P; Phillips RE; McMichael AJ
    J Exp Med; 1997 Apr; 185(8):1423-33. PubMed ID: 9126923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.
    Cohen WM; Bianco A; Connan F; Camoin L; Dalod M; Lauvau G; Ferriès E; Culmann-Penciolelli B; van Endert PM; Briand JP; Choppin J; Guillet JG
    J Virol; 2002 Oct; 76(20):10219-25. PubMed ID: 12239297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines.
    Singh RA; Barry MA
    J Immunol; 2004 Oct; 173(7):4387-93. PubMed ID: 15383568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.
    Hückelhoven AG; Etschel JK; Bergmann S; Zitzelsberger K; Mueller-Schmucker SM; Harrer EG; Harrer T
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):528-35. PubMed ID: 25900164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for CD8 cytotoxic T lymphocytes specific for Gag of human immunodeficiency virus type 1 subtype B' Henan isolate from China and identification of novel epitopes restricted by the HLA-A2 and HLA-A11 alleles.
    Gong X; Gui X; Zhang Y; Tien P
    J Gen Virol; 2006 Jan; 87(Pt 1):151-158. PubMed ID: 16361427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.